USPTO serial 87425955
RNANIMAL
Reviewed by CopyMark Law Group
Reg. 5593015Status 710
- Filing date
- Status date
- Registration date
- Oct 30, 2018
- Examiner
- KEAM, ALEX S
- Law office
- PETITIONS OFFICE
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with RNANIMAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
TÜBINGEN, DE
Tubingen, DE
Tubingen, DE
Tubingen, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer Fraser
Jennifer Fraser Dykema Gossett PLLC1301 K St., NWSuite 1100 WestWashington, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents and biomolecules, in particular biological macromolecules for industry and science, reagents for research purposes | SECTION 8 - CANCELLED | — |
| 005 | Chemical preparations for pharmaceutical or medical or veterinary medical purposes or pharmaceutical and veterinary medical preparations, in particular for therapeutic or prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases or of heritable genetic diseases or for therapies replacing proteins or enzymes; immunostimulatory compositions, in particular for veterinary medical purposes; vaccines, in particular for veterinary medical purposes; adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases or for therapies replacing proteins or enzymes; gene therapy products for human or veterinary use; gene therapy products, namely, nucleic acid macromolecules for in vivo expression; food supplements for veterinary medical use | SECTION 8 - CANCELLED | — |
| 042 | Scientific and technological services, namely, technical consulting and scientific research services, in particular for identifying and characterizing biological macromolecules | SECTION 8 - CANCELLED | — |
| 044 | Medical and veterinary services, in particular for therapeutical and prophylactic treatment of tumor diseases, infectious diseases, autoimmune diseases or allergies, of hereditary disorders, of allergies, and for protein or enzyme supplement therapy for therapeutic or prophylactic treatment of neurological, neuromuscular, neurodegenerative and cardiovascular disorders and for the treatment of endocrinological disorders | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CUREVAC SE
- Other trademarks owned by CureVac AG
- Other trademarks owned by CureVac AG
- Other trademarks owned by CureVac AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RNANIMAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 16, 2025 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 30, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 8, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 30, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 26, 2018 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Sep 25, 2018 | APET | ASSIGNED TO PETITION STAFF | — |
| Aug 29, 2018 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Aug 14, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 14, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 25, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 6, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 29, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 29, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 28, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jun 13, 2018 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 12, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 12, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 5, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 5, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 5, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 31, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 30, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 30, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 1, 2017 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 1, 2017 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 1, 2017 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jul 24, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| May 4, 2017 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| May 3, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 29, 2017 | NWAP | NEW APPLICATION ENTERED | — |